Syros pharmaceuticals merger

Author: guhf

August undefined, 2024

WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol "SYRS," and will be led by Syros’ existing management team,...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Receives Average ...

WebSep 20, 2024 · Syros Pharmaceuticals has recently acquired its peer Tyme Technologies. The sole purpose of the merger was to acquire TYME's cash balance. Concurrently with … WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing … chick fil a in bonney lake

Table of Contents - ir.syros.com

WebSep 15, 2024 · The new CUSIP number for Syros’ common stock following the reverse stock split is 87184Q206. On September 15, 2024, the holders of a majority of Syros’ … WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement News Download as PDF July 05, 2024 Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance … WebNov 14, 2024 · Closed Merger with TYME Technologies and Concurrent PIPE; Proceeds from Combined Transactions Augment Cash Balance, Ending Third Quarter with … chick fil a in brandon

Syros to Raise Approximately $190 Million Through Merger with …

WebJul 5, 2024 · Syros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME ), including its pipeline assets and net cash, after … WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement Business Wire July 5, 2024, 4:00 AM · 16 … chick fil a in bowie mdWebExhibit 4.2 . SYROS PHARMACEUTICALS, INC. and . Trustee . INDENTURE . Dated as of SENIOR DEBT SECURITIES chick fil a in bloomington

"WebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME's expected net cash at closing and … " - Syros pharmaceuticals merger

Syros pharmaceuticals merger

Press Releases :: Syros Pharmaceuticals, Inc. (SYRS)

WebApr 15, 2024 · Syros Pharmaceuticals, Inc engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by... WebSyros Pharmaceuticals, Inc. 35 CambridgePark Drive, 4th Floor . Cambridge, Massachusetts 02140 (617) 744-1340 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Nancy Simonian, M.D. President and Chief Executive Officer.

Did you know?

WebApr 7, 2024 · Syros Pharmaceuticals is part of the Pharmaceuticals industry, and located in Massachusetts, United States. Syros Pharmaceuticals Location 35 Cambridge Park Dr, Cambridge, Massachusetts, 02140, United States Description Read More Industry Pharmaceuticals Healthcare Discover more about Syros Pharmaceuticals Beth Ann Work …

WebAug 9, 2024 · Definitive Merger Agreement with TYME Technologies and Concurrent PIPE Expected to Close 2H 2024 and Bring Combined Proceeds of Approximately $190 Million, … WebJul 5, 2024 · Development stage biotech firms Syros Pharmaceuticals ( SYRS) and Tyme Technologies ( NASDAQ: TYME) announced on Tuesday that the companies entered into …

WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of … WebSep 16, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of …

WebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME’s expected net cash at closing and …

WebNov 22, 2024 · Syros and Tyme Technologies Announce Stockholder Approval of Merger Sep 13, 2024 Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment … gordons chemist magherafeltWebMar 2, 2024 · Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dec 12, 2024 Syros Pharmaceuticals Announces Publication in Blood Advances … gordons chemist linenhall streetWebKEY WINS: Steered the strategic and operational integration of Tyme Inc. into Syros Pharmaceuticals following an acquisition. Now driving business for an artificial intelligence-powered... gordons chemist irelandWebApr 15, 2024 · Syros Pharmaceuticals has a 1-year low of $2.42 and a 1-year high of $12.93. Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) last released its quarterly earnings … chick fil a in bransonWebTyme Technologies, Inc., a biotechnology company developing cancer metabolism-based therapies, completed its acquisition by merger with Syros Pharmaceuticals, Inc., a leader … chick fil a in brea caWebJul 5, 2024 · Concurrent with the merger, Syros announced an oversubscribed $130 million private investment in public equity (PIPE) financing at a price per unit of $0.94. New and … gordons chemist offersWebSep 16, 2024 · CAMBRIDGE, Mass., September 16, 2024 -- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that … gordons chemist newtownabbey